Last synced on 25 April 2025 at 11:05 pm

Implant, Resorbable, For Articular Osteochondral Repair

Page Type
Product Code
Definition
This device is intended to repair knee joint surface cartilage or osteochondral lesions.
Physical State
The device is a cell-free, off-the-shelf implant for use in cartilage and osteochondral defects in traumatic and osteoarthritic joints. The implant is a porous, biodegradable scaffold, consisting of interconnected natural calcium carbonate (aragonite) derived from purified, inorganic coral exoskeleton. It has a cylindrical shape with tapered sides for press-fit implantation into bone.
Technical Method
The device is implanted into a drilled hole through the defect and into the underlying bone. It gradually resorbs and is replaced by bone tissue. The material functions as a scaffold, encouraging filling of knee joint surface defects with new tissue.
Target Area
Knee joint articular cartilage and underlying bone
Review Panel
Orthopedic
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QRU to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Implant, Resorbable, For Articular Osteochondral Repair

Page Type
Product Code
Definition
This device is intended to repair knee joint surface cartilage or osteochondral lesions.
Physical State
The device is a cell-free, off-the-shelf implant for use in cartilage and osteochondral defects in traumatic and osteoarthritic joints. The implant is a porous, biodegradable scaffold, consisting of interconnected natural calcium carbonate (aragonite) derived from purified, inorganic coral exoskeleton. It has a cylindrical shape with tapered sides for press-fit implantation into bone.
Technical Method
The device is implanted into a drilled hole through the defect and into the underlying bone. It gradually resorbs and is replaced by bone tissue. The material functions as a scaffold, encouraging filling of knee joint surface defects with new tissue.
Target Area
Knee joint articular cartilage and underlying bone
Review Panel
Orthopedic
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QRU to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.